According to Merck's latest financial reports the company's current revenue (TTM) is $60.11 B. In 2022 the company made a revenue of $59.28 B an increase over the years 2021 revenue that were of $48.70 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $60.11 B | 1.4% |
2022 | $59.28 B | 21.72% |
2021 | $48.70 B | 8.58% |
2020 | $44.85 B | -4.24% |
2019 | $46.84 B | 10.75% |
2018 | $42.29 B | 5.41% |
2017 | $40.12 B | 0.79% |
2016 | $39.80 B | 0.78% |
2015 | $39.49 B | -6.48% |
2014 | $42.23 B | -4.08% |
2013 | $44.03 B | -6.84% |
2012 | $47.26 B | -1.62% |
2011 | $48.04 B | 4.48% |
2010 | $45.98 B | 67.66% |
2009 | $27.42 B | 15% |
2008 | $23.85 B | -1.44% |
2007 | $24.19 B | 6.9% |
2006 | $22.63 B | 2.84% |
2005 | $22.01 B | -4.04% |
2004 | $22.93 B | 2.01% |
2003 | $22.48 B | -49.27% |
2002 | $44.32 B | -7.11% |
2001 | $47.71 B |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $89.65 B | 49.15% | ๐บ๐ธ USA |
Novartis NVS | $49.92 B | -16.95% | ๐จ๐ญ Switzerland |
Pfizer PFE | $58.49 B | -2.69% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $40.10 B | -33.28% | ๐บ๐ธ USA |
Eli Lilly LLY | $35.93 B | -40.23% | ๐บ๐ธ USA |
Amgen AMGN | $28.19 B | -53.11% | ๐บ๐ธ USA |
Sanofi SNY | $50.51 B | -15.97% | ๐ซ๐ท France |
Bristol-Myers Squibb BMY | $45.53 B | -24.25% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $38.54 B | -35.88% | ๐ฌ๐ง UK |
Teva Pharmaceutical Industries TEVA | $15.84 B | -73.64% | ๐ฎ๐ฑ Israel |